Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis

Liver International

Volumn 32, Issue 9, 2012, Pages 1327-1332

  Theocharidou, Eleni ^a   Krag, Aleksander ^b   Bendtsen, Flemming ^b   Møller, Søren ^b   Burroughs, Andrew K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adrenal insufficiency; Cirrhotic cardiomyopathy; QT interval

Indexed keywords

ALDOSTERONE; BETA ADRENERGIC RECEPTOR; CARBON MONOXIDE; CATECHOLAMINE; CORTICOTROPIN; ENDOCANNABINOID; HYDROCORTISONE; INTERLEUKIN 6; MUSCARINIC M2 RECEPTOR; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL DISEASE; ADRENAL INSUFFICIENCY; ADRENALECTOMY; CIRRHOTIC CARDIOMYOPATHY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DOWN REGULATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PROTECTION; HEPATORENAL SYNDROME; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOVOLEMIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEMBRANE FLUIDITY; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; PATHOGENESIS; QT PROLONGATION; REPOLARIZATION; REVIEW; SYSTOLIC DYSFUNCTION; T WAVE INVERSION; TACHYCARDIA; VASCULAR RESISTANCE;

ADRENAL GLANDS; ADRENAL INSUFFICIENCY; ARRHYTHMIAS, CARDIAC; CATECHOLAMINES; DOWN-REGULATION; GLUCOCORTICOIDS; HUMANS; LIVER CIRRHOSIS; LONG QT SYNDROME; MINERALOCORTICOIDS; RECEPTORS, ADRENERGIC, BETA; VENTRICULAR DYSFUNCTION;

EID: 84861454735     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02751.x     Document Type: Review

References (39)

1. Møller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010; 53: 179-90.
2. Liu H, Lee SS. Acute-on-chronic liver failure: the heart and systemic hemodynamics. Curr Opin Crit Care 2011; 17: 190-4.
3. Kazankov K, Holland-Fischer P, Andersen NH, et al. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int 2011; 31: 534-40.
4. Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis 2008; 28: 59-69.
5. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009; 3: 294-304.
6. Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42: 439-47.
7. Møller S, Krag A. Cardiorenal syndrome - a new entity? In: Gerbes A, ed. Hyponatremia and Hepatorenal Syndrome: Progress in Treatment. Basel: Karger, 2011; 102-11.
8. Krag A, Bendtsen F, Henriksen JH, Møller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010; 59: 105-10.
9. Møller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9-15.
10. Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology 1996; 110: 1191-8.
11. Jaue DN, Ma Z, Lee SS. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy. Hepatology 1997; 25: 1361-5.
12. Ward CA, Liu H, Lee SS. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy. Gastroenterology 2001; 121: 1209-18.
13. Zardi EM, Abbate A, Zardi DM, et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010; 56: 539-49.
14. Rasaratnam B, Connelly N, Chin-Dusting J. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination? Clin Sci (Lond) 2004; 107: 425-34.
15. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002; 122: 1784-96.
16. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-49.
17. Marik PE, Gayowski T, Starzl TE. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005; 33: 1254-9.
18. Fede G, Spadaro L, Tomaselli T, et al. Assessment of adrenocortical reserve in stable patients with cirrhosis. J Hepatol 2011; 54: 243-50.
19. Triantos CK, Marzigie M, Fede G, et al. Critical illness-related corticosteroid insufficiency in patients with cirrhosis and variceal bleeding. Clin Gastroenterol Hepatol 2011; 9: 595-601.
20. Galbois A, Rudler M, Massard J, et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol 2010; 52: 839-45.
21. Tan T, Chang L, Woodward A, et al. Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. J Hepatol 2010; 53: 841-8.
22. Daniluk J, Szuster-Ciesielska A, Drabko J, Kandefer-Szerszen M. Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol 2001; 23: 29-34.
23. O'Beirne J, Holmes M, Agarwal B, et al. Adrenal insufficiency in liver disease - what is the evidence? J Hepatol 2007; 47: 418-23.
24. Eckhart AD. Mineralocorticoid receptors, corticosteroids and the heart: where do we stand? J Hypertens 2010; 28: 889-91.
25. Collins S, Caron MG, Lefkowitz RJ. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263: 9067-70.
26. Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8: 473-9.
27. Sambhi MP, Weil MH, Udhoji VN. Acute pharmacodynamic effects of glucocorticoids; cardiac output and related hemodynamic changes in normal subjects and patients in shock. Circulation 1965; 31: 523-30.
28. DeGroot WJ. Cardiomyopathy associated with endocrine disorders. Cardiovasc Clin 1972; 4: 305-31.
29. Eto K, Koga T, Sakamoto A, et al. Adult reversible cardiomyopathy with pituitary adrenal insufficiency caused by empty sella-a case report. Angiology 2000; 51: 319-23.
30. Lefer AM, Verrier RL, Carson WW. Cardiac performance in experimental adrenal insufficiency in cats. Circ Res 1968; 22: 817-27.
31. Fallo F, Betterle C, Budano S, et al.Regression of cardiac abnormalities after replacement therapy in Addison's disease. Eur J Endocrinol 1999; 140: 425-8.
32. Krag A, Møller S, Burroughs AK, Bendtsen F Betablockers induce cardiac chronotropic incompetence. J Hepatol 2012; 56: 298-9.
33. Gerbes AL, Remien J, Jungst D, Sauerbruch T, Paumgartner G. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1986; 1: 1409-11.
34. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451-9.
35. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 1131-7.
36. Niebauer J. Inflammatory mediators in heart failure. Int J Cardiol 2000; 72: 209-13.
37. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 2003; 93: 388-98.
38. Van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol 1996; 24: 747-52.
39. Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int 2003; 23: 243-8.